HIC-Vac funding
Funding boost for Network tackling infectious diseases
An international network hosted at Imperial has been awarded additional funding to improve vaccines for infectious diseases.
Funding boost for Network tackling infectious diseases
An international network hosted at Imperial has been awarded additional funding to improve vaccines for infectious diseases.
Increasing vaccine coverage in developing countries focus of new Imperial hub
A 10 million pound Future Vaccine Manufacturing Hub led by Imperial College London has officially launched.
Research shows flu vaccine reduces NHS staff sickness
New study from Imperial College London shows that improving NHS flu vaccination programmes can reduce staff sickness, to help cope with winter demand.
Bacterial population struggles can affect the potential of vaccines
Scientists have shown how vaccinating against a common cause of pneumonia leads to lethal strains of bacteria being replaced by less harmful strains.
Pneumonia bacteria's 'evolutionary hotspot' helps it to evade the immune system
The diverse 'coats' which protect a deadly microbe from our immune cells are generated by a 'hotspot' of rapidly evolving genes, a study has found.
Free universal healthcare reduces health inequality in Brazil
Expanding access to primary healthcare has helped to reduce health inequalities between racial groups in Brazil.
4
Imperial celebrates 'bumper crop' of new Fellows
Eight Imperial researchers have been elected to the Fellowship of the Academy of Medical Sciences.
European region most sceptical in the world on vaccine safety
Europe has been named as the most sceptical region on vaccine safety in the world, in the largest ever global survey of vaccine confidence.
How Zika and dengue can turn the immune system against itself
Dr Abigail Culshaw is a Research Associate in the Department of Medicine, and discussed the dengue epidemic at this year's Imperial Festival.
Disproportionate and devastating: Professor Danny Altmann on the Zika virus